Susceptibility to killer T cells of gastric cancer cells enhanced by Mitomycin-C involves induction of ATBF1 and activation of p21 (Waf1/Cip1) promoter.
D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins / Q000378:metabolism* / Q000502:physiology; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D006801:Humans; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology*; D016685:Mitomycin / Q000494:pharmacology*; D011401:Promoter Regions, Genetic / Q000187:drug effects*; D012097:Repressor Proteins / Q000302:isolation & purification; D015398:Signal Transduction; D013274:Stomach Neoplasms / Q000473:pathology; D014407:Tumor Cells, Cultured; D000509:alpha-Fetoproteins / Q000502:physiology
C493956:CDKN1A protein, human; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins; D012097:Repressor Proteins; D000509:alpha-Fetoproteins; D016685:Mitomycin